Medical research

President Donald Trump speaks during an event on the food supply chain amid the coronavirus pandemic, in the Roosevelt Room of the White House, Tuesday, May 19, 2020, in Washington. (AP Photo/Evan Vucci)
May 20, 2020 - 6:36 am
WASHINGTON (AP) — President Donald Trump emphatically defended himself against criticism from medical experts that his announced use of a malaria drug against the coronavirus could spark wide misuse by Americans of the unproven treatment with potentially fatal side effects. Trump's revelation a day...
Read More
A chemist displays hydroxychloroquine tablets in Mumbai, India, Tuesday, May 19, 2020. President Donald Trump’s declaration that he was taking the antimalarial drug of dubious effectiveness to help fend off the coronavirus will be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring the world’s largest producer of the drug to make much more of it, prescribe it for front-line health workers treating cases of the coronavirus and deploy it as a diplomatic tool, despite mounting evidence against using the drug for COVID-19. (AP Photo/Rafiq Maqbool)
May 19, 2020 - 8:50 pm
NEW DELHI (AP) — President Donald Trump’s declaration that he was taking a malaria drug of dubious effectiveness to help fend off the coronavirus will likely be welcomed in India. Trump's previous endorsement of hydroxychloroquine catalyzed a tremendous shift in the South Asian country, spurring...
Read More
Veterans Affairs Secretary Robert Wilkie speaks about protecting seniors, in the East Room of the White House, Thursday, April 30, 2020, in Washington. (AP Photo/Alex Brandon)
May 16, 2020 - 12:14 am
WASHINGTON (AP) — Facing growing criticism, the Department of Veterans Affairs said Friday that it will not halt use of an unproven malaria drug on veterans with COVID-19 but that fewer of its patients are now taking it. In responses provided to Congress and obtained by The Associated Press, the VA...
Read More
FILE - In this March 16, 2020 file photo, a patient receives a shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. In a press briefing on Thursday May 14, 2020, the European Medicines Agency predicted that there could be licensed drugs to treat the new coronavirus in the next few months and that a vaccine might even be approved in early 2021, in a “best-case scenario.” (AP Photo/Ted S. Warren, File)
May 14, 2020 - 7:19 am
LONDON (AP) — The European Medicines Agency predicted that there could be licensed drugs to treat the new coronavirus in the next few months and that a vaccine might even be approved in early 2021, in a “best-case scenario.” Dr. Marco Cavaleri, who heads the European regulator’s vaccines department...
Read More
FILE - In this Tuesday, Jan. 23, 2018 file photo, a doctor, center, directs a special camera to look at a patient's tumor at a hospital in Philadelphia. According to research released on Wednesday, May 13, 2020, cancer deaths have dropped more in states that expanded Medicaid coverage under the Affordable Care Act than in states that did not. (AP Photo/Matt Rourke)
May 13, 2020 - 5:02 pm
Cancer deaths have dropped more in states that expanded Medicaid coverage under the Affordable Care Act than in states that did not, new research reveals. The report Wednesday is the first evidence tying cancer survival to the health care change, which began in 2014 after the law known as “...
Read More
Pedestrians walk through the nearly empty Oculus during the coronavirus pandemic Saturday, May 9, 2020, in New York. (AP Photo/Frank Franklin II)
May 11, 2020 - 9:07 pm
NEW YORK (AP) — New York City’s death toll from the coronavirus may be thousands of fatalities worse than the tally kept by the city and state, according to an analysis released Monday by the U.S. Centers for Disease Control and Prevention. Between March 11 and May 2, about 24,000 more people died...
Read More
FILE - This Monday, April 6, 2020 file photo shows an arrangement of hydroxychloroquine tablets in Las Vegas. According to results released on Thursday, May 7, 2020, a new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection. Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 consecutive patients treated at Columbia University Irving Medical Center in New York. (AP Photo/John Locher)
May 07, 2020 - 5:17 pm
A new study finds no evidence of benefit from a malaria drug widely promoted as a treatment for coronavirus infection. Hydroxychloroquine did not lower the risk of dying or needing a breathing tube in a comparison that involved nearly 1,400 patients treated at Columbia University in New York,...
Read More
FILE- In this file photo dated Monday, May 4, 2020, a statue wears a mask along Trocadero square close to the Eiffel Tower in Paris. In a study published Tuesday May 5, 2020, in the International Journal of Microbial Agents, doctors at a hospital north of Paris reviewed retrospective samples of 14 patients treated for atypical pneumonia, and say they may have identified a possible case of the new coronavirus dating back to December 2019. (AP Photo/Christophe Ena, FILE)
May 05, 2020 - 7:41 am
LONDON (AP) — French scientists say they may have identified a possible case of the new coronavirus dating back to December — about a month before the first cases were officially confirmed in Europe. In a study published in the International Journal of Microbial Agents, doctors at a hospital north...
Read More
In this screen grab from video issued by Britain's Oxford University, a volunteer is injected with either an experimental COVID-19 vaccine or a comparison shot as part of the first human trials in the U.K. to test a potential vaccine, led by Oxford University in England on April 25, 2020. About 100 research groups around the world are pursuing vaccines against the coronavirus, with nearly a dozen in early stages of human trials or poised to start. (University of Oxford via AP)
May 04, 2020 - 1:14 am
WASHINGTON (AP) — Hundreds of people are rolling up their sleeves in countries across the world to be injected with experimental vaccines that might stop COVID-19, spurring hope — maybe unrealistic — that an end to the pandemic may arrive sooner than anticipated. About 100 research groups are...
Read More
FILE - In this March 2020 photo provided by Gilead Sciences, a vial of the investigational drug remdesivir is visually inspected at a Gilead manufacturing site in the United States. On Wednesday, April 29, 2020, the company says its experimental antiviral drug has proved effective against the new coronavirus in a major U.S. government study that put it to a strict test. (Gilead Sciences via AP)
April 29, 2020 - 1:31 pm
An experimental drug has proved effective against the new coronavirus in a major study, shortening the time it takes for patients to recover by four days on average, U.S. government and company officials announced Wednesday. Gilead Sciences’s remdesivir is the first treatment to pass such a strict...
Read More

Pages